HIGH-grade atrioventricular heart block in patients with coronary artery disease is generally thought to be irreversible and in most cases atropine produces little or no effect.' Nevertheless, the possibility of significant vagal action should always be considered in any patient with heart block. When such a factor is present, the administration of atropine will produce a striking improvement in atrioventricular conduction.
HIGH-grade atrioventricular heart block in patients with coronary artery disease is generally thought to be irreversible and in most cases atropine produces little or no effect.' Nevertheless, the possibility of significant vagal action should always be considered in any patient with heart block. When such a factor is present, the administration of atropine will produce a striking improvement in atrioventricular conduction.
We are presenting detailed observations on an unusual patient with heart block: chronic atrioventricular block of the Wenckebach type was associated with severe coronary artery disease and congestive heart failure; atropine abolished the block, prevented Stokes-Adams attacks, and controlled an increase in the block that was produced by digitalis. These observations indicate that there may be functional as well as organic components in this type of heart block, and emphasize the importance of testing the ef. fects of atropine in such patients. CASE HISTORY L. R., an 85-year-old man, was admitted to the Beth Israel Hospital in October 1955 because of increasing congestive heart failure. He had had 2 acute myocardial infarctions (in 1943 and 1951) followed by angina pectoris and congestive heart failure. In 1951 he began to have episodes of syncope associated with first-degree heart block (P-R interval 0.30 second) and sinus bradyeardia ( the ventricular rate was sometimes as low as 4 beats in 10 seconds and the patient complained of lightheadedness and dizziness. Accordingly, digoxin was omitted and atropine administration (1.2 mg. by mouth every 6 hours) was continued.
The action of atropine sulfate was studied in detail (days 19 to 23) as the effects of digoxin on atrioventricular conduction disappeared. Figure  3 shows the changes observed between 2 oral 1.2 mg. doses of atropine sulfate given 6 hours apart on the second day after the digoxin was stopped (day 20). At the time of the first dose, there were 16 dropped beats per minute, the P-R interval varied between 0.28 and 0.38 second, and the P-P interval ranged from 1.05 to 1.13 seconds. At the height of the atropine effect, 11/2 hours after the dose, all sinoatrial beats were conducted to the ventricle, the P-R interval was stable although still longer than normal, and there was no sinus arrythmia. At 31/2 hours after the dose, the sinus arrhythmia reappeared, at 5 hours the P-R interval again began to vary, and at 51/2 hours dropped beats were again observed. 
REVERSIBLE ATRIOVENTRICULAR BLOCK
Atropine abolished the spontaneous block, indicating that the conduction defect was caused by intrinsic vagal activity. This observation is striking, since it is most unusual for atropine to abolish such a high degree of heart block in a patient with severe coronary artery disease. ' Carotid sinus pressure, digoxiii, and exercise increased the block. These effects were of vagal origin as shown by the fact that atropine abolished them.
Marked sensitivity of the heart to reflex vagal stimulation is often observed in patients with coronary artery disease as shown by the frequent finding of a hyperactive carotid sinus reflex. Usually the sinoatrial node is more sensitive to carotid sinus stimulation than the atrioventricular node, and considerable slowing of the sinoatrial rate occurs before there is any appreciable effect on conduction.3 In this patient, however, the atrioventricular node was far more sensitive than the sinoatrial node, and light carotid sinus pressure produced complete heart block although there was no slowing of the sinoatrial rate.
That digoxin increased the block in this patient is clear on the following grounds: the same phenomenon had been observed several times before when a cardiac glycoside had been given; such high degrees of block (3 :2 and 2 :1) were never observed in the resting state at other times; and conduction returned to its previous state 4 days after digoxin was stopped, as would be expected from the known duration of action of the drug. Although cardiac glycosides do not ordinarily affect preexisting heart block,4 it is well recognized that they may interfere with atrioventricular conduction through a vagal mechanism as was observed in this patient. This vagomimetic action should tiot be confused with the direct action of the glycosides on conductioii, which may be observed with larger doses and which is not changed by atropine. 
